NCT04373187View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetic Comparability of CC-93538 From Two Different Drug Concentrations in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

CC-93538

one injection of 2mL

DRUG

CC-93538

two injections of 1.2mL

Trial Locations (1)

78744

PPD Phase 1 Clinic, Austin

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY